Oklahoma Heart Institute

Tulsa, Oklahoma 74137

10 studies enrolling now · 51 studies all time

What they study most

Abdominal Aortic Aneurysm, Acute DVT of Lower Extremity, Aortic Stenosis, Calcific, Aortic Stenosis, Severe, Aortic Valve Insufficiency, Aortic Valve Stenosis, Arrhythmia, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Bradycardia, CIED Related Infection, Cardiac Pacemaker, Artificial

Studies at this site

• Assessment of CCM in HF With Higher Ejection Fraction — Recruiting now
• ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves — Recruiting now
• Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System — Recruiting now
• Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System — Recruiting now
• ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve — Recruiting now
• A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease — Recruiting now
• xDot Access Management System Early Feasibility Study — Recruiting now
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) — Recruiting now
• Nectero EAST System Clinical Study — Recruiting now
• The ENCIRCLE Trial — Recruiting now
• PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR — Recruiting now
• Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial — Running, not enrolling
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System — Running, not enrolling
• Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study — Paused
• Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation — Completed
• Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial — Running, not enrolling
• TRISCEND II Pivotal Trial — Running, not enrolling
• A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension — Running, not enrolling
• CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
• A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia — Completed
• FlowTriever2 Pulmonary Embolectomy Clinical Study — Completed
• ClotTriever Outcomes (CLOUT) Registry — Completed
• Destination Therapy Post Approval Study — Running, not enrolling
• remedē System Therapy Study — Running, not enrolling
• Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS) — Completed
• Apogee, A HeartWare HVAD Destination Product Surveillance Registry (PSR) Platform — Completed
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) — Completed
• Protect the Head to Head Study — Status unconfirmed
• A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) — Completed
• Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial — Completed
• RESPECT Trial - (Rapid Extravascular Sealing Via PercutanEous Collagen ImplanT) — Completed
• Attain Stability™ Quad Clinical Study — Completed
• EverFlex Post Approval Study — Completed
• World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
• Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy — NO_LONGER_AVAILABLE
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• Transcaval Access for Transcatheter Aortic Valve Replacement in People With No Good Options for Aortic Access — Completed
• Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter — Completed
• Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) — Completed
• The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System — Completed
• Medtronic Reveal LINQ™ In-Office 2 (RIO 2) Study United States — Completed
• Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery — Stopped early
• Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access — Completed
• Evaluation of Multisensor Data in Heart Failure Patients With Implanted Devices — Completed
• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function — Completed
• Advisa MRI Clinical Study — Completed
• Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response — Completed